Granata Bio has acquired 1 company, including 1 in the last 5 years.
Granata Bio has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
289 St. George Street, Suite 209,
Duxbury, Massachusetts
02332
United States,
www.granata.bio
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2025-04-29 |
Oviva Therapeutics · Life Science
New York, New York · www.ovivatx.com Oviva Therapeutics improves women's experience of aging through biomedical research, development, and advocacy. The company addresses the need in women's health by expanding funding, research, and clinical development, and is currently developing first-in-class therapeutics to improve ovarian function and consequently extend female healthspan. Oviva Therapeutics is based in New York City. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
